GlassScriptPhysician profile
Alexander Trujillo
NPI 1255595609
$14,322.72
in general payments reported to CMS, 2019-2025
44 companies · $1,456 in 2025
The $1,456 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,567 · 2020: $906 · 2021: $1,213 · 2022: $1,004 · 2023: $1,586 · 2024: $1,592 · 2025: $1,456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,520 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,519.92 |
| Education | $113.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $5,705.32 | 2019-2020 | |
| Medtronic, INC. | $849.43 | 2021-2025 | Endurant Iis, Symplicity G3, Onyx Frontier |
| Boston Scientific Corporation | $801.22 | 2019-2025 | Watchman Flx, Watchman Access System, Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $601.12 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $588.36 | 2019-2025 | Farxiga |
| Abbott Laboratories | $582.67 | 2019-2025 | Xience Skypoint, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Merck Sharp & Dohme LLC | $558.56 | 2021-2025 | Verquvo, Capvaxive |
| Bard Peripheral Vascular, INC. | $496.45 | 2019-2025 | Venclose Maven Catheter |
| Novartis Pharmaceuticals Corporation | $457.49 | 2019-2025 | |
| Amgen INC. | $415.35 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $408.87 | 2019-2025 | Jardiance |
| Abiomed | $297.79 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $296.33 | 2019-2025 | Lifevest |
| Pfizer INC. | $244.74 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $211.56 | 2023-2025 | Opsumit, Uptravi |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $178.34 | 2019-2025 | Camzyos, Eliquis |
| Impulse Dynamics (USA) INC. | $178.11 | 2023 | Optimizer |
| Endologix LLC | $173.72 | 2025 | Endocross Device, Torus Stent Graft System |
| Esperion Therapeutics, INC. | $168.04 | 2020-2024 | Nexletol |
| Edwards Lifesciences Corporation | $126.15 | 2023-2025 | Sapien 3 Ultra Resilia, Pascal |
| Heartflow, INC. | $120.95 | 2024 | |
| Novo Nordisk INC | $113.68 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Baxter Healthcare | $111.70 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $106.09 | 2023-2024 | Inpefa |
| Tactile Systems Technology INC | $60.68 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Kowa Pharmaceuticals America, INC. | $49.36 | 2021-2022 | |
| Biosense Webster, INC. | $38.23 | 2023 | Carto 3 |
| Arbor Pharmaceuticals, INC. | $34.02 | 2021-2022 | |
| Cashflow Solutions, LLC | $29.81 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Stryker Corporation | $29.73 | 2024-2025 | N/A |
| Kci USA, INC. | $27.43 | 2023 | Activ.A.C., V.A.C. Veraflo Cleanse Choice, Prevena |
| Alnylam Pharmaceuticals INC. | $27.12 | 2022 | |
| Kestra Medical Technology Services, INC. | $23.53 | 2024 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $23.00 | 2019 | |
| Biotronik INC. | $22.08 | 2019 | |
| Astellas Pharma US INC | $21.80 | 2019 | |
| Cook Medical LLC | $21.41 | 2022 | |
| Angiodynamics, INC. | $20.65 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $20.62 | 2024 | Arcalyst |
| Cardiovascular Systems INC. | $18.72 | 2019 | |
| Chiesi USA, INC. | $18.30 | 2022 | |
| Bard Access Systems, INC. | $16.65 | 2019 | |
| Amicus Therapeutics, INC. | $16.24 | 2021 | |
| Infobionic, INC | $11.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Trujillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.